Ketamine can slow gut motility through several pharmacological mechanisms, and some people do experience constipation during or after its use. But the relationship is more complicated than a simple yes-or-no, because ketamine acts on the gut in competing ways, and the clinical context matters enormously. In surgical settings, for instance, ketamine-based pain protocols have actually been linked to faster return of bowel function, largely because they reduce the need for opioids, which are far more constipating. Understanding why ketamine affects the gut the way it does helps explain why one person walks away bloated while another barely notices a change.
How Ketamine Slows Gut Muscle Directly
Your intestines move food along through rhythmic contractions of smooth muscle, and ketamine can interfere with that process at the cellular level. Lab studies on intestinal tissue show that ketamine suppresses the calcium signals that smooth muscle cells need to contract. In one study on mouse intestinal tissue, ketamine at a concentration of 100 micromoles reduced muscle contractions by about 40% and suppressed the underlying intracellular calcium response by roughly 65%.1Fiziolohichnyĭ zhurnal. Inhibitory Action of the General Anesthetic Ketamine on Intracellular Calcium Transients and Smooth Muscle Contractions of the Mouse Small Intestine Separate research has confirmed that ketamine’s ability to relax intestinal smooth muscle is tied to its blocking of L-type calcium channels, which are the main gateways for calcium entry into muscle cells.2PubMed. Ketamine inhibits contractile responses of intestinal smooth muscle by decreasing the influx of calcium through the L-type calcium channel
These are in-vitro and animal findings, so they don’t translate directly to what happens in a person taking a clinical dose. But they establish a clear mechanism: ketamine can physically slow down the muscle contractions that push material through the intestines. If those contractions weaken enough, transit time increases, stool dries out, and constipation follows.
Opioid Receptors and a Double Hit
One of ketamine’s less well-known actions is that it behaves as a mild opioid agonist. Classic opioids like morphine are infamous for causing constipation because they activate receptors in the gut wall that slow motility, reduce secretions, and increase the tone of sphincters. Ketamine does something similar, though to a lesser degree. In guinea-pig intestinal tissue, ketamine showed agonistic activity on opioid receptors, and the opioid-blocking drug naloxone partially reversed the effect.3Neuropharmacology. Assessment of the potential agonistic and antagonistic properties of ketamine at opiate receptors in the guinea-pig ileum On top of the opioid activity, the same study found that ketamine also depressed the gut’s contractile response to acetylcholine and histamine, two signaling molecules involved in normal bowel motility.
So ketamine delivers something of a double hit: it mimics opioids at one receptor while simultaneously dampening the gut’s response to its own pro-motility signals. Neither effect is as strong as what you would see from a dedicated opioid painkiller, but together they can be enough to tip someone toward sluggish digestion, especially at higher doses or with repeated exposure.
The Enteric Nervous System Angle
Your gut has its own nervous system, often called the “second brain,” and it contains NMDA receptors, the same type of receptor that ketamine is best known for blocking in the brain. These gut NMDA receptors are thought to play a role in both pain signaling and motility reflexes.4European Journal of Pharmacology. The effects of NMDA receptor antagonists over intestinal ischemia/reperfusion injury in rats You might expect, then, that blocking them with ketamine would predictably slow the gut. But the research here introduces a wrinkle.
An animal study that specifically tested ketamine’s effect on intestinal propulsive reflexes found that the drug did reduce gut motility, but only at doses much higher than those used in standard anesthesia or clinical depression treatment. At typical anesthetic infusion rates, propulsive reflexes were not affected. Only when doses were pushed to several times the clinical range did motility drop by about 30%. The researchers concluded that ketamine’s gut-slowing effects at higher doses were likely due to actions on nicotinic receptors rather than NMDA receptors.5PubMed. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo This matters because it suggests that for people receiving a single low-dose infusion for depression, the direct gut-slowing effect through the enteric nervous system is probably modest. The constipation risk rises with dose and duration.
Sympathetic Stimulation and What It Means for Your Gut
Ketamine is well documented to stimulate the sympathetic nervous system, the “fight or flight” branch of autonomic control.6PubMed. Ketamine When sympathetic activity ramps up, your body diverts resources away from digestion. Heart rate and blood pressure climb, while the gut slows down. This is a normal physiological response, not unique to ketamine, but it adds another layer to the constipation picture. If you are receiving ketamine in a setting that also involves anxiety, unfamiliar surroundings, or physical stress, the sympathetic contribution to slowed digestion can be amplified.
For most people getting a brief clinical infusion, this effect is temporary and resolves as the drug wears off. But for someone receiving repeated treatments or using ketamine recreationally over longer periods, the repeated sympathetic surges may contribute to a pattern of irregular bowel habits that is hard to attribute to any single mechanism.
The Sphincter of Oddi Problem and “Ketamine Cramps”
Not all ketamine-related gut complaints are classic constipation. Chronic users, especially recreational users consuming large amounts, frequently report intense abdominal cramping that has been linked to dysfunction of the sphincter of Oddi, a small muscular valve that controls the flow of bile and pancreatic juice into the small intestine. Ketamine appears to trigger spasm of this valve by activating muscarinic receptors in the sphincter tissue.7PubMed Central. Sphincter of oddi dysfunction induced by ketamine – A case report
When the sphincter of Oddi goes into spasm, bile backs up, pressure builds in the biliary system, and the result is severe upper abdominal pain sometimes called “ketamine cramps” or “K-cramps.” A systematic review of chronic ketamine misuse described these episodes as “excruciating gastrointestinal episodes” triggered by sphincter of Oddi dyskinesia.8PubMed. The K-Hole Collapse – A Systematic Review of Multi-Organ Somatotoxicity and Management Strategies in Chronic Ketamine Misuse While this is distinct from constipation in the traditional sense, the pain, bloating, and disrupted digestion can easily be mistaken for it. People experiencing recurrent abdominal distress during chronic ketamine use should be aware that the biliary system, not just the bowel, may be the source.
Chronic recreational use also brings broader gastrointestinal toxicity, including abdominal pain, liver function abnormalities, and bile duct damage.9Elsevier (Toxicologie Analytique et Clinique). Toxicity patterns associated with chronic ketamine exposure The urinary tract gets most of the attention in discussions of long-term ketamine damage, but the GI system takes a real beating too.
When Ketamine Actually Speeds Up Bowel Recovery
Here is where the picture flips in an interesting way. In surgical settings, where postoperative constipation and sluggish bowel recovery (ileus) are major concerns, ketamine-based pain protocols have sometimes been associated with faster return of normal gut function, not slower. The reason is straightforward: ketamine is an excellent opioid-sparing agent. By providing effective pain control through a non-opioid pathway, it lets surgeons and anesthesiologists use far less morphine and its relatives, which are dramatically more constipating than ketamine itself.
In a randomized trial of patients undergoing gynecological abdominal surgery, those who received S-ketamine as part of their anesthesia had their first postoperative gas passage at about 50 hours on average, compared with roughly 57 hours for the control group.10PubMed Central. S-ketamine promotes postoperative recovery of gastrointestinal function and reduces postoperative pain in gynecological abdominal surgery patients – a randomized controlled trial That is a modest but real acceleration of bowel recovery. In another study involving patients undergoing bladder-removal surgery, a ketamine-based pain regimen was associated with first bowel movement at three days versus six days in patients managed with a morphine-heavy protocol, and the ketamine group used dramatically less morphine overall.11Canadian Urological Association Journal. Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion
The takeaway here is that ketamine’s net effect on your gut depends on what it is replacing. If ketamine is added on top of a full opioid regimen, its own mild constipating properties add to the pile. But if it is being used to reduce or eliminate opioid use, the math can work in the other direction. This is why many enhanced recovery protocols in surgery now include ketamine as a way to get bowels moving again sooner.
Why Context Matters More Than the Drug Itself
People encounter ketamine in wildly different settings, and the constipation risk is not uniform across them. A single low-dose intravenous infusion for treatment-resistant depression delivers a relatively small amount of ketamine over 40 minutes. At these doses, direct gut-slowing effects are likely minimal based on the animal data showing that motility changes required doses well above the clinical range.5PubMed. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo Any constipation that occurs around a depression infusion is more likely related to the sedation, reduced fluid intake during the treatment session, or pre-existing constipation from the depression itself (which frequently disrupts gut motility through other pathways).
Repeated infusion protocols, where patients receive ketamine two or three times a week for several weeks, present a greater cumulative exposure. And oral or sublingual ketamine, increasingly prescribed for at-home use, introduces the drug directly into the GI tract before it reaches the bloodstream, so local effects on gut tissue could be more pronounced than with intravenous delivery, although direct clinical data comparing constipation rates by route are scarce.
Recreational use sits at the far end of the spectrum. Doses are often many times higher than clinical amounts, use may be daily, and the drug is frequently combined with alcohol, other sedatives, or substances that have their own GI effects. The biliary and hepatic damage seen in chronic recreational users is essentially absent from clinical treatment studies, underscoring how much the dose-frequency-duration triad matters.
What You Can Do About It
If you are receiving ketamine for a medical condition and notice constipation developing, the standard first-line approaches for any drug-related constipation apply. Staying well hydrated before and after treatments is the simplest and most overlooked intervention. Ketamine sessions can involve fasting beforehand and reduced oral intake for hours afterward, so fluid deficits add up quickly. Physical movement, even gentle walking, helps stimulate gut motility through mechanical and neural pathways that operate independently of whatever ketamine is doing to smooth muscle.
Over-the-counter options include osmotic laxatives like polyethylene glycol, which draw water into the bowel and soften stool without stimulating muscle contractions, making them a good first choice for drug-related constipation. Stool softeners like docusate are also commonly recommended, though evidence for their effectiveness as standalone agents is modest. Stimulant laxatives like bisacodyl or senna work more aggressively and are best reserved for when gentler measures have failed.
Dietary fiber helps in the long term but can actually worsen bloating and discomfort in the short term if you increase intake suddenly, especially when gut motility is already compromised. A gradual increase paired with adequate fluids is the safer approach. Probiotic supplements are popular but evidence for their benefit in drug-induced constipation specifically is limited.
If constipation becomes persistent or severe during a ketamine treatment course, the conversation with your prescriber should include whether the treatment schedule can be adjusted, whether an alternative formulation might produce fewer GI effects, or whether a prokinetic medication is warranted. Do not simply push through weeks of misery without raising it; clinicians managing ketamine therapy are familiar with GI complaints and can usually adjust the approach.
The Emerging Microbiome Connection
An area of active research is how ketamine interacts with the gut microbiome, the community of bacteria and other microorganisms in your intestines that influence digestion, immune function, and even mood. Early evidence suggests that ketamine may actually have some restorative effects on microbial balance, including normalization of short-chain fatty acid levels, which are produced by gut bacteria during fiber fermentation and play important roles in maintaining bowel regularity.12Nature Molecular Psychiatry. Pleiotropic modulation of the gut-brain-lung axis by ketamine and its enantiomers This is a tantalizing finding because short-chain fatty acids promote colonic motility and water absorption, meaning that if ketamine supports their production, it could partially counterbalance the drug’s direct constipating effects.
This research is still in its early stages, mostly from animal models and mechanistic studies rather than large clinical trials in humans. But it adds to the picture of ketamine as a pharmacologically messy drug in the gut: slowing things down through some pathways while potentially supporting healthy function through others. It also opens the door to future interventions where targeted probiotics or prebiotic fibers could be paired with ketamine therapy to protect bowel regularity, though that remains speculative for now.
Ketamine and Irritable Bowel Syndrome
An intriguing development is the investigation of low-dose esketamine as a potential treatment for irritable bowel syndrome. A registered clinical trial protocol is currently recruiting patients with IBS across mild, moderate, and severe categories to test whether a single low dose of esketamine given during colonoscopy can improve IBS symptom scores, including bowel habit measures like stool form assessed on the Bristol Stool Scale.13BMJ Open. Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome – study protocol for a randomised controlled trial The rationale is that ketamine’s effects on visceral pain signaling and central sensitization could reset the overactive pain-motility cycle that drives IBS symptoms.
Results are not yet available, but the trial’s existence highlights an important nuance: the same drug that can cause constipation in one context might treat a bowel disorder in another. IBS is not simply about motility; it involves abnormal pain processing, gut-brain signaling, and mucosal immune activation. Ketamine’s ability to modulate pain pathways through NMDA receptor blockade makes it a candidate for conditions where the nervous system’s relationship with the gut has gone haywire, even if the drug has its own direct slowing effects on muscle.
If you have pre-existing IBS, especially the constipation-predominant subtype, it is worth flagging this for your prescriber before starting ketamine therapy. Your baseline bowel function is already compromised, so even a mild additional slowing effect could push you into significant discomfort. On the other hand, if your IBS is driven heavily by visceral hypersensitivity and pain, ketamine’s analgesic properties might actually provide relief. The direction the scale tips will depend on your individual symptom profile, and there is no substitute for monitoring your own response closely during the first few treatment sessions.